Two Sigma Securities’s GSK GSK Stock Holding History

Two Sigma Securities’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,600	Closed	-$412K	–	3243
2024 Q1	$412K	Sell	9,600 -1,300	-12%	-$53.6K	﹤0.01%	1717
2023 Q4	$404K	Buy	10,900 +2,600	+31%	+$93.3K	﹤0.01%	1717
2023 Q3	$301K	Buy	+8,300	New	+$295K	﹤0.01%	1962
2023 Q2	–	Sell	-7,300	Closed	-$260K	–	3001
2023 Q1	$260K	Buy	+7,300	New	+$255K	0.01%	1846
2022 Q2	–	Sell	-4,960	Closed	-$270K	–	2472
2022 Q1	$270K	Buy	+4,960	New	+$269K	0.01%	1480
2020 Q4	–	Sell	-6,080	Closed	-$286K	–	1773
2020 Q3	$286K	Sell	6,080 -8,160	-57%	-$409K	0.01%	898
2020 Q2	$726K	Buy	+14,240	New	+$731K	0.02%	495
2020 Q1	–	Sell	-96,720	Closed	-$5.68M	–	1720
2019 Q4	$5.68M	Buy	96,720 +24,960	+35%	+$1.39M	0.04%	356
2019 Q3	$3.83M	Buy	71,760 +24,720	+53%	+$1.27M	0.03%	376
2019 Q2	$2.35M	Buy	47,040 +37,360	+386%	+$1.87M	0.02%	421
2019 Q1	$506K	Sell	9,680 -22,720	-70%	-$1.14M	﹤0.01%	875
2018 Q4	$1.55M	Sell	32,400 -107,840	-77%	-$5.31M	0.02%	456
2018 Q3	$7.04M	Sell	140,240 -141,040	-50%	-$7.17M	0.05%	291
2018 Q2	$14.2M	Sell	281,280 -139,680	-33%	-$7.04M	0.07%	210
2018 Q1	$20.6M	Buy	+420,960	New	+$19.6M	0.12%	148

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Two Sigma Securities's GSK Position: Q2 2025 in Review

Two Sigma Securities sold out of GSK (GSK) in Q2 2025, closing a stake of 7,353 shares — an estimated $285K sold.

Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters. The position peaked at $1.85M in Q2 2023. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Two Sigma Securities reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 7,353 GSK shares in Q2 2025, an estimated $285K.
Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters.
Two Sigma Securities's GSK position peaked at $1.85M in Q2 2023.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.